ArticleBone marrow transplantation2009

Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT.

M Ditschkowski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.